Pharmaceutical Network March 7 News 2015，The Drug Review Center of the State Food and Drug Administration continues to uphold quality、Fairness、Principles of Efficiency，Adhere to laws and regulations、Scientific Normal review，Approved 342 pharmaceutical production (listing) registration applications (76 Chinese medicine、241 pieces of chemicals、25 pieces of biological products)，Applying for 1673 drug clinical trial registration applications (22 Chinese medicine、1565 pieces of chemicals、86 biological products)。

2015，State Food and Drug Administration based on drug review recommendations，For the first time, I approved anal acetic acid、stake sports betting appstake betting appIntestinal Virus 71 Initant Vaccine (EV71)、injection for glycosidase & alpha; (rare disease treatment medicine)、Demonine Parry peptide injection (rare disease therapy)、New drugs in important treatment areas such as glimmeris saponin capsules，Provide patients with the possibility of obtaining the latest treatment methods，At the same time, domestic generic drugs such as polyethylene glycol modification interferon，It provides important guarantees for the availability and payment of the patient's medication。

"2015 Annual Drug Review Report" for drug registration accepted throughout the year、The overall situation of review and approval was explained，For chemicals、Acceptance of Chinese medicine and biological stake sports betting appproducts、Review data and stake sports betting appreview time limit for analysis。

Learn the specific content of the "2015 Drug Review Report"，Please log in to the website of the Pharmaceutical Review Center of the State Food and Drug Administration。URL: http: //www.cde.org.cn